Sign In
Buy NKTR
$72.76
+2.17 (+3.07%)
At Close: Aug 04, 2026
Earnings Preview: Nektar Therapeutics (NKTR) Q2 Earnings Expected to Decline
04:33pm, Thursday, 30'th Jul 2020
Nektar (NKTR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the second quarter 2020 on Thursday, August 6, 2020, after the close of U.S.-based financial markets. Howard Robin, President
Candriam Luxembourg S.C.A. Sells 70,071 Shares of Nektar Therapeutics (NASDAQ:NKTR)
06:54am, Monday, 27'th Jul 2020
Candriam Luxembourg S.C.A. reduced its position in Nektar Therapeutics (NASDAQ:NKTR) by 18.2% during the second quarter, according to the company in its most recent 13F filing with the Securities & Ex
IPO Update: Pandion Therapeutics Seeks $94 Million IPO
02:48pm, Tuesday, 14'th Jul 2020
Pandion Therapeutics has filed proposed terms for its IPO. The company is developing treatments for gastrointestinal and liver diseases.
Die Mücke tötet durchschnittlich 725'000 Menschen pro Jahr - Blick
10:42am, Saturday, 04'th Jul 2020
Sie stoppte Hannibal vor Rom, vernichtete die indigene Bevölkerung Amerikas, schaffte aber auch die Sklaverei ab: Kein Tier hat die Menschheitsgeschichte mehr geprägt als die Mücke wie ein neues B
Medicenna Company Update And Upcoming Catalysts
12:38pm, Wednesday, 01'st Jul 2020
Medicenna's IL-2 engineered Superkine MDNA11 recently replaced MDNA19 as Medicenna's potential best-in-class IL2 candidate to move forward. IND to be filed and
Analyzing Creative Realities (CRDF) and Its Peers
02:40am, Tuesday, 30'th Jun 2020
Creative Realities (NASDAQ: CRDF) is one of 141 public companies in the “Biological products, except diagnostic” industry, but how does it compare to its competitors? We will compare Creative Real
Global Oncology Drugs Market Outlook 2020-2030: COVID-19 Impact and Recovery Assessment - ResearchAndMarkets.com
12:00am, Tuesday, 30'th Jun 2020
The
Nektar Therapeutics (NASDAQ: NKTR) Q1 2020 Earnings Call Transcript | AlphaStreet
03:08pm, Friday, 26'th Jun 2020
Final earnings conference call transcript of Nektar Therapeutics - NKTR stock
Manche mögen´s heiß!
08:00am, Thursday, 25'th Jun 2020
DIE UMWELTBERATUNG stellt in einem neuen Poster robuste Pflanzen für die Zeiten des Klimawandels vor.
Erstaunlich viele Bienen-Arten in Zürich - Blick
07:13am, Wednesday, 24'th Jun 2020
Wer sagt denn, Grossstädte seien lebensfeindliche Biotope? Die Stadt Zürich jedenfalls verfügt über eine derartige Vielfalt an Wildbienen, die selbst Forscher überrascht: 164 der in der Schweiz h
Hedge Funds Aren’t Impressed By Nektar Therapeutics (NKTR)
01:46am, Wednesday, 24'th Jun 2020
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Ev
Maverick Capital Ltd. Raises Stock Holdings in Nektar Therapeutics (NASDAQ:NKTR)
07:44am, Tuesday, 23'rd Jun 2020
Maverick Capital Ltd. boosted its stake in Nektar Therapeutics (NASDAQ:NKTR) by 51.1% during the 1st quarter, Holdings Channel reports. The institutional investor owned 4,898,401 shares of the biophar
Brookfield Properties Is Suing Gap Over Missed Rent Payments | The Motley Fool
04:59pm, Monday, 22'nd Jun 2020
Retailer said it is negotiating with landlords over a "fair" rent to pay.
Thrivent Financial for Lutherans Has $2.30 Million Stock Holdings in Nektar Therapeutics (NASDAQ:NKTR)
09:35am, Monday, 22'nd Jun 2020
Thrivent Financial for Lutherans boosted its position in Nektar Therapeutics (NASDAQ:NKTR) by 179.7% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 128,589 shares
